MedTrace Logo

Pain Relief for Birth Control Implants Insertion

NCT03187392 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2018-02-27

No results posted yet for this study

Summary

The aim of our study is to compare the analgesic effect of topical application of lidocaine-prilocaine cream and lidocaine infiltration during insertion of birth control implants

Conditions

  • Contraception
  • Lidocaine

Interventions

DRUG

Lidocaine Injectable Product

3 cm of Lidocaine- will be injected subcutaneous for 5 minutes before insertion of subcutaneous birth control implant

DRUG

Lidocaine Topical Cream [LMX]

3 mg of Lidocaine- will be applied to skin for 5 minutes before insertion of subcutaneous birth control implant

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-12
Primary Completion
2018-09-16
Completion
2018-09-18

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03187392 on ClinicalTrials.gov